| Patent | Date |
|---|
Method for treating diseases associated with abnormal kinase activity
App 20060140947 - Lyons; John ; et al. | 2006-06-29 |
Sequential therapy comprising a 20(S)-camptothecian and a pyrimidine base analog
App 20060052334 - Rubinfeld; Joseph ; et al. | 2006-03-09 |
Method for treating diseases associated with abnormal kinase activity
Grant 6,998,391 - Lyons , et al. February 14, 2 | 2006-02-14 |
Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analog
Grant 6,977,247 - Rubinfeld , et al. December 20, 2 | 2005-12-20 |
Camptothecin complexes
App 20050209190 - Rubinfeld, Joseph ; et al. | 2005-09-22 |
Combination therapy including 9-nitro-20(S)-camptothecin
App 20050130882 - Rubinfeld, Joseph | 2005-06-16 |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
App 20050118180 - Rubinfeld, Joseph | 2005-06-02 |
Compositions and methods for treatment of cancer
App 20050059682 - Rubinfeld, Joseph | 2005-03-17 |
Pharmaceutical formulation
App 20050043225 - Rubinfeld, Joseph | 2005-02-24 |
Methods for administration of paclitaxel
Grant 6,828,346 - Joshi-Hangal , et al. December 7, 2 | 2004-12-07 |
Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylation
App 20040224919 - Rubinfeld, Joseph ; et al. | 2004-11-11 |
Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
App 20040167205 - Joshi-Hangal, Rajashree ; et al. | 2004-08-26 |
Method for treating diseases associated with abnormal kinase activity
App 20040127453 - Lyons, John ; et al. | 2004-07-01 |
Combination HIV therapy including camptothecin
App 20040116411 - Schochetman, Gerald ; et al. | 2004-06-17 |
Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylation
App 20040109846 - Rubinfeld, Joseph ; et al. | 2004-06-10 |
Sequential therapy comprising a 20(S)-camptothecin and an anthracycline
App 20040097437 - Rubinfeld, Joseph | 2004-05-20 |
Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
Grant 6,710,195 - Joshi-Hangal , et al. March 23, 2 | 2004-03-23 |
Restoring cancer-suppressing functions to neoplastic cells through DNA hypomethylation
App 20040052864 - Rubinfeld, Joseph ; et al. | 2004-03-18 |
Pharmaceutical formulation
App 20040014695 - Rubinfeld, Joseph | 2004-01-22 |
Combination therapy including 9-nitro-20(S)-camptothecin and bleomycin
Grant 6,664,233 - Rubinfeld December 16, 2 | 2003-12-16 |
Methods for administration of paclitaxel
App 20030191179 - Joshi-Hangal, Rajashree ; et al. | 2003-10-09 |
Camptothecin conjugates
Grant 6,629,995 - Wrenn, Jr. , et al. October 7, 2 | 2003-10-07 |
Sequential therapy comprising a 20(S)-camptothecin and an anthracycline
Grant 6,627,614 - Rubinfeld September 30, 2 | 2003-09-30 |
Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation
Grant 6,613,753 - Rubinfeld , et al. September 2, 2 | 2003-09-02 |
Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analog
App 20030158148 - Rubinfeld, Joseph ; et al. | 2003-08-21 |
Camptothecin complexes
App 20030148996 - Rubinfeld, Joseph ; et al. | 2003-08-07 |
Paclitaxel formulation
Grant 6,538,020 - Joshi-Hangal , et al. March 25, 2 | 2003-03-25 |
Paclitaxel formulation
Grant 6,509,370 - Joshi-Hangal , et al. January 21, 2 | 2003-01-21 |
Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation
App 20020114809 - Rubinfeld, Joseph ; et al. | 2002-08-22 |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
App 20020111362 - Rubinfeld, Joseph | 2002-08-15 |
Paclitaxel formulation
App 20020103254 - Joshi-Hangal, Rajashree ; et al. | 2002-08-01 |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
Grant 6,420,378 - Rubinfeld July 16, 2 | 2002-07-16 |
Combination therapy including 9-nitro-20(S)-camptothecin and 5-fluorouracil
App 20020086818 - Rubinfeld, Joseph | 2002-07-04 |
Formulation of nitrogen mustard
App 20020058634 - Rubinfeld, Joseph | 2002-05-16 |
Oral formulation for paclitaxel
Grant 6,319,943 - Joshi , et al. November 20, 2 | 2001-11-20 |
Combination therapy including 9-nitro-20(S)-camptothecin
Grant 6,191,119 - Rubinfeld February 20, 2 | 2001-02-20 |
Formulation for paclitaxel
Grant 6,136,846 - Rubinfeld , et al. October 24, 2 | 2000-10-24 |
Pharmaceutical formulation
Grant 6,048,845 - Rubinfeld April 11, 2 | 2000-04-11 |
Water-miscible pharmaceutical compositions
Grant 6,017,948 - Rubinfeld , et al. January 25, 2 | 2000-01-25 |
Method and compositions for solubilization and stabilization of polypeptides, especially proteins
Grant 5,997,856 - Hora , et al. December 7, 1 | 1999-12-07 |
Formulation for administration of steroid compounds
Grant 5,824,668 - Rubinfeld , et al. October 20, 1 | 1998-10-20 |
Pharmaceutical formulation
Grant 5,804,568 - Rubinfeld September 8, 1 | 1998-09-08 |
Method and compositions for solubilization and stabilization of polypeptides, especially proteins
Grant 5,730,969 - Hora , et al. March 24, 1 | 1998-03-24 |
Pharmaceutical formulation
Grant 5,602,112 - Rubinfeld February 11, 1 | 1997-02-11 |
Detergents
Grant 4,061,603 - Rubinfeld * December 6, 1 | 1977-12-06 |
| 